Detalhe da pesquisa
1.
The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1.
Mol Cancer
; 20(1): 141, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34727930